0.9% 氯化钠注射剂,USP BD PosiFlush SF 注射器
K号: K153481 · 2016-04-04
广告
器械摘要
常见问题
What is the 0.9% Sodium Chloride Injection, USP BD PosiFlush SF Syringe?
0.9% Sodium Chloride Injection, USP BD PosiFlush SF Syringe is a medical device that received FDA 510(k) clearance on 2016-04-04. The listed applicant is Becton, Dickinson and Company. The 510(k) number is K153481.
When did 0.9% Sodium Chloride Injection, USP BD PosiFlush SF Syringe receive FDA 510(k) clearance?
0.9% Sodium Chloride Injection, USP BD PosiFlush SF Syringe received FDA 510(k) clearance on 2016-04-04, under 510(k) number K153481.
Who is the listed applicant for 0.9% Sodium Chloride Injection, USP BD PosiFlush SF Syringe?
The FDA 510(k) record lists Becton, Dickinson and Company as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for 0.9% Sodium Chloride Injection, USP BD PosiFlush SF Syringe?
The FDA product code for 0.9% Sodium Chloride Injection, USP BD PosiFlush SF Syringe is NGT.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
列明Becton, Dickinson and Company为申报人的其他记录
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
相关器械(代码:NGT)
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。
广告